UBS Group’s HUMANIGEN, INC. HGEN Stock Holding History

UBS Group’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,430	Closed	-$218	–	10325
2023 Q2	$218	Sell	1,430 -321,302	-100%	-$50K	﹤0.01%	8377
2023 Q1	$46.1K	Buy	322,732 +116,581	+57%	+$18.7K	﹤0.01%	6512
2022 Q4	$24.7K	Buy	206,151 +153,695	+293%	+$22.2K	﹤0.01%	7429
2022 Q3	$10K	Buy	52,456 +51,314	+4,493%	+$27.6K	﹤0.01%	8506
2022 Q2	$2K	Hold	1,142	–	–	﹤0.01%	9708
2022 Q1	$3K	Sell	1,142 -13,264	-92%	-$35.5K	﹤0.01%	9546
2021 Q4	$53K	Sell	14,406 -435,317	-97%	-$2.55M	﹤0.01%	6848
2021 Q3	$2.67M	Buy	449,723 +435,197	+2,996%	+$6.11M	﹤0.01%	3327
2021 Q2	$253K	Sell	14,526 -74,152	-84%	-$1.35M	﹤0.01%	5188
2021 Q1	$1.69M	Buy	+88,678	New	+$1.62M	﹤0.01%	3738
2020 Q4	–	Sell	-1,790	Closed	-$19K	–	8923
2020 Q3	$19K	Buy	+1,790	New	+$18.4K	﹤0.01%	6363

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

UBS Group's HGEN Position: Q3 2023 in Review

UBS Group sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 1,430 shares — an estimated $218 sold.

UBS Group first reported a position in HGEN in Q3 2020 and held it in 11 quarters. The position peaked at $2.67M in Q3 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

UBS Group reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
UBS Group sold 1,430 HUMANIGEN, INC. shares in Q3 2023, an estimated $218.
UBS Group first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 11 quarters.
UBS Group's HUMANIGEN, INC. position peaked at $2.67M in Q3 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.